Are Platelet Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC) stem cells and BioD Restore® all considered regenerative therapies?
No. While platelet rich plasma (PRP) accelerates the body’s ability to heal itself through the aid of growth factors, is not considered a regenerative therapy.
Bone marrow aspirate concentrate (BMAC) and BioD Restore®, on the other hand, are considered regenerative therapies because they assist with both healing acceleration and tissue regeneration. The additional “pluripotent” stem cells withdrawn from the patient and used for the BMAC procedure are “undifferentiated”, meaning they are able to replicate themselves into (or regenerate) various types of tissue. The same is true for BioD Restore® placental tissue graft “pluripotent” cells, but these are derived from the chorionic “Live Birth” placental tissue that was donated by pre-screened mothers.
BMAC stem cells are “autologous” tissue taken from a patient’s own Iliac pelvic bone.
BioD Restore® is a donor tissue from the chorionic side of the “live birth” placenta that has been donated by mothers who were prescreened and agreed to donate their placentas. This tissue does NOT need to be a “match” for the recipient because the chorionic placental tissue, and stem cells in general, are non-reactive to histocompatibility antigens, thus no graft-vs-host reactions occur.